Epidermal Growth Factor Receptor (EGFR) Testing for Advanced Non-Small Cell Lung Cancer | Cancer.Net

IntroductionThe American Society of Clinical Oncology (ASCO) has issued a provisional clinical opinion on using epidermal growth factor receptor (EGFR) testing to help predict the benefit of treating patients with advanced non-small cell lung cancer with

www.cancer.net